{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T17:44:06Z","timestamp":1706204646591},"reference-count":16,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PRA"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>The present disclosure relates to p38\u03b1 mitogen-activated protein kinase\ninhibitors, pharmaceutical compositions thereof, and the use of the p38\u03b1 mitogen-activated\nprotein kinase inhibitors and pharmaceutical compositions thereof for treating various diseases\nsuch as cancer, rheumatoid arthritis, amyotrophic lateral sclerosis, cystic fibrosis, cardiovascular\ndisease, multiple sclerosis, inflammatory bowel disease, chronic obstructive pulmonary disease\n(COPD), asthma, COVID-19, acute respiratory distress syndrome (ARDS), and acute lung injury\n(ALI).<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574892818666221202111605","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:46:20Z","timestamp":1670305580000},"page":"549-551","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel 4-chloro-N-phenyl Benzamide Derivatives as p38\u03b1 Mitogenactivated\nProtein Kinase Inhibitors for Treating Cancer, COVID-19, and\nOther Diseases"],"prefix":"10.2174","volume":"18","author":[{"given":"Surya K.","family":"De","sequence":"first","affiliation":[{"name":"Department of Chemistry, Institute of Conju-Probe, San Diego, California, USA"},{"name":"Department of Chemistry, Bharath\nUniversity, Chennai, Tamil Nadu, 600126, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1126\/science.7914033","volume":"265","author":"Han J.","year":"1994","unstructured":"Han J.; Lee J.D.; Bibbs L.; Ulevitch R.J.; A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994,265(5173),808-811","journal-title":"Science"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1568009622666220215142837","volume":"22","author":"Denny W.A.","year":"2022","unstructured":"Denny W.A.; Inhibitors and activators of the p38 Mitogen-Activated MAP Kinase (MAPK) family as drugs to treat cancer and inflammation. Curr Cancer Drug Targets 2022,22(3),209-220","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/ijms23010370","volume":"23","author":"Garc&#xED;a-Hern&#xE1;ndez L.","year":"2021","unstructured":"Garc&#xED;a-Hern&#xE1;ndez L.; Garc&#xED;a-Ortega M.B.; Ruiz-Alcal&#xE1; G.; Carrillo E.; Marchal J.A.; Garc&#xED;a M.&#xC1;.; The p38 MAPK components and modulators as biomarkers and molecular targets in cancer. Int J Mol Sci 2021,23(1),370","journal-title":"Int J Mol Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3390\/cells10123466","volume":"10","author":"Maik-Rachline G.","year":"2021","unstructured":"Maik-Rachline G.; Wortzel I.; Seger R.; Alternative splicing of MAPKs in the regulation of signaling specificity. Cells 2021,10(12),3466","journal-title":"Cells"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/erm.2021.29","volume":"24","author":"Wang L.","year":"2022","unstructured":"Wang L.; Xia Z.; Tang W.; p38 activation and viral infection. Expert Rev Mol Med 2022,24,e4","journal-title":"Expert Rev Mol Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2217","volume":"31","author":"Chander Y.","year":"2021","unstructured":"Chander Y.; Kumar R.; Khandelwal N.; Role of p38 mitogen\u2010activated protein kinase signalling in virus replication and potential for developing broad spectrum antiviral drugs. Rev Med Virol 2021,31(5),1-16","journal-title":"Rev Med Virol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yjmcc.2020.05.007","volume":"144","author":"Grimes J.M.","year":"2020","unstructured":"Grimes J.M.; Grimes K.V.; p38 MAPK inhibition: A promising therapeutic approach for COVID-19. J Mol Cell Cardiol 2020,144,63-65","journal-title":"J Mol Cell Cardiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.4049\/jimmunol.1602059","volume":"198","author":"Shah N.G.","year":"2017","unstructured":"Shah N.G.; Tulapurkar M.E.; Ramarathnam A.; Novel noncatalytic substrate selective p38&#x3B1;-specific MAPK inhibitors with endothelial stabilizing and anti-inflammatory activity. J Immunol 2017,198(8),3296-3306","journal-title":"J Immunol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1517\/13543780903321490","volume":"18","author":"Yong H.Y.","year":"2009","unstructured":"Yong H.Y.; Koh M.S.; Moon A.; The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opin Investig Drugs 2009,18(12),1893-1905","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"120809","DOI":"10.1016\/j.lfs.2022.120809","volume":"306","author":"Malekinejad Z.","year":"2022","unstructured":"Malekinejad Z.; Baghbanzadeh A.; Nakhlband A.; Recent clinical findings on the role of kinase inhibitors in COVID-19 management. Life Sci 2022,306,120809","journal-title":"Life Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"781352","DOI":"10.3389\/fimmu.2021.781352","volume":"12","author":"Cioccarelli C.","year":"2021","unstructured":"Cioccarelli C.; S&#xE1;nchez-Rodr&#xED;guez R.; Angioni R.; IL1&#x3B2; promotes TMPRSS2 expression and SARS-CoV-2 cell entry through the p38 MAPK-GATA2 Axis. Front Immunol 2021,12,781352","journal-title":"Front Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384101.2022.2100575","volume":"21","author":"Valipour M.","year":"2022","unstructured":"Valipour M.; Irannejad H.; Emami S.; Application of emetine in SARS-CoV-2 treatment: regulation of p38 MAPK signaling pathway for preventing emetine-induced cardiac complications. Cell Cycle 2022,21(22),1-8","journal-title":"Cell Cycle"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.stemcr.2022.01.015","volume":"17","author":"Ma Z.","year":"2022","unstructured":"Ma Z.; Li X.; Fan R.L.Y.; A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4. Stem Cell Reports 2022,17(3),538-555","journal-title":"Stem Cell Reports"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"120732","DOI":"10.1016\/j.lfs.2022.120732","volume":"305","author":"Alshehade S.","year":"2022","unstructured":"Alshehade S.; Alshawsh M.A.; Murugaiyah V.; The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions. Life Sci 2022,305,120732","journal-title":"Life Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1038\/s41388-022-02329-3","volume":"41","author":"Kudaravalli S.","year":"2022","unstructured":"Kudaravalli S.; den Hollander P.; Mani S.A.; Role of p38 MAP kinase in cancer stem cells and metastasis. Oncogene 2022,41(23),3177-3185","journal-title":"Oncogene"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1124\/jpet.108.139006","volume":"327","author":"Hill R.J.","year":"2008","unstructured":"Hill R.J.; Dabbagh K.; Phippard D.; Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: Preclinical analysis of efficacy and selectivity. J Pharmacol Exp Ther 2008,327(3),610-619","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Recent Patents on Anti-Cancer Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574892818666221202111605","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211545\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574892818666221202111605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T15:58:16Z","timestamp":1692892696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211545\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574892818666221202111605","relation":{},"ISSN":["1574-8928"],"issn-type":[{"value":"1574-8928","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-08-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}